Annual EBITDA
-$602.13M$75.42M-14.32%
Summary
- Current Value
- As of today, CYTK annual EBITDA is -$602.13M, down -14.32% on
- Historical Performance
- CYTK annual EBITDA is down -90.67% over the past 3 years, down -553.70% over the past 5 years
- All-Time High Comparison
- CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on
- 3-Year Low Comparison
- CYTK annual EBITDA is at its 3-year low
- Sector Comparison
- CYTK annual EBITDA is higher than 1.06% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$602.13M | -14.3% | -90.7% | -553.7% | -1161.4% | |
| Quarterly EBITDA | -$175.54M | -60.7% | -47.2% | -223.6% | -1224.1% | |
| TTM EBITDA | -$695.36M | -29.4% | -47.5% | -458.3% | -1353.2% | |
| Price | $76.84 | +101.9% | +133.3% | +151.4% | +1168.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $88.04M | +376.6% | -6.9% | +57.7% | +3316.3% | |
| Annual EPS | -$6.54 | -24.1% | -50.9% | -231.3% | -41.5% | |
| -$612.26M | -14.2% | -88.8% | -551.7% | -1133.5% | ||
| Annual Net Income | -$784.96M | -33.1% | -101.8% | -516.7% | -1492.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$315.80M | N/A | -90.7% |
| 5Y | -$92.11M | N/A | -553.7% |
| All | $28.09M | -2243.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$602.13M | at low | |
| 5Y | -$602.13M | at low | |
| All | -$602.13M | at low |
EBITDA History
FAQ
- What is the current annual EBITDA of CYTK?
- As of today, CYTK annual EBITDA is -$602.13M
- What is 1-year change in CYTK annual EBITDA?
- CYTK annual EBITDA is down -14.32% year-over-year
- What is 3-year change in CYTK annual EBITDA?
- CYTK annual EBITDA is down -90.67% over the past 3 years
- How far is CYTK annual EBITDA from its all-time high?
- CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on December 31, 2009
- How does CYTK annual EBITDA rank versus sector peers?
- CYTK annual EBITDA is higher than 1.06% of companies in Healthcare sector
- When is CYTK next annual earnings release?
- As of today, the next annual earnings release for CYTK has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$175.54M$4.70M+2.61%
Summary
- Current Value
- As of today, CYTK quarterly EBITDA is -$175.54M, up +2.61% on
- Historical Performance
- CYTK quarterly EBITDA is down -60.72% year-over-year, down -47.19% over the past 3 years
- All-Time High Comparison
- CYTK quarterly EBITDA is currently -402.07% below its historical high of $58.11M set on
- 3-Year Low Comparison
- CYTK quarterly EBITDA is +2.61% above its 3-year low of -$180.24M reached on
- Sector Comparison
- CYTK quarterly EBITDA is higher than 0.85% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$175.54M | +2.6% | -60.7% | -47.2% | -223.6% | |
| Annual EBITDA | -$602.13M | – | -14.3% | -90.7% | -553.7% | |
| TTM EBITDA | -$695.36M | -10.5% | -29.4% | -47.5% | -458.3% | |
| Price | $76.84 | -1.6% | +101.9% | +133.3% | +151.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $28.62M | +47.9% | -57.1% | +3201.5% | +906.8% | |
| Quarterly EPS | -$1.50 | +10.0% | -33.8% | -12.0% | -75.4% | |
| -$179.17M | +2.4% | -60.7% | -46.8% | -227.0% | ||
| Quarterly Net Income | -$198.76M | +3.5% | -47.9% | -54.5% | -222.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$109.22M | N/A | -60.7% |
| 3Y | -$109.22M | -60.7% | |
| 5Y | -$8.87M | -1878.6% | |
| All | $58.11M | -402.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$180.24M | +2.6% | |
| 3Y | -$180.24M | +2.6% | |
| 5Y | -$180.24M | +2.6% | |
| All | -$180.24M | +2.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of CYTK?
- As of today, CYTK quarterly EBITDA is -$175.54M
- What is CYTK quarterly EBITDA most recent change?
- CYTK quarterly EBITDA was up +2.61% on June 30, 2026
- What is 1-year change in CYTK quarterly EBITDA?
- CYTK quarterly EBITDA is down -60.72% year-over-year
- How far is CYTK quarterly EBITDA from its all-time high?
- CYTK quarterly EBITDA is currently -402.07% below its historical high of $58.11M set on June 30, 2009
- How does CYTK quarterly EBITDA rank versus sector peers?
- CYTK quarterly EBITDA is higher than 0.85% of companies in Healthcare sector
- When is CYTK next earnings release?
- The next earnings release for CYTK is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$695.36M$66.32M-10.54%
Summary
- Current Value
- As of today, CYTK TTM EBITDA is -$695.36M, down -10.54% on
- Historical Performance
- CYTK TTM EBITDA is down -29.35% year-over-year, down -47.45% over the past 3 years
- All-Time High Comparison
- CYTK TTM EBITDA is currently -2465.10% below its historical high of $29.40M set on
- 3-Year Low Comparison
- CYTK TTM EBITDA is at its 3-year low
- Sector Comparison
- CYTK TTM EBITDA is higher than 0.76% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$695.36M | -10.5% | -29.4% | -47.5% | -458.3% | |
| Annual EBITDA | -$602.13M | – | -14.3% | -90.7% | -553.7% | |
| Quarterly EBITDA | -$175.54M | +2.6% | -60.7% | -47.2% | -223.6% | |
| Price | $76.84 | -1.6% | +101.9% | +133.3% | +151.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $67.67M | -36.0% | -21.1% | +580.0% | +17.1% | |
| TTM EPS | -$7.22 | -5.5% | -41.0% | -26.9% | -230.4% | |
| -$707.91M | -10.6% | -29.4% | -46.9% | -459.0% | ||
| TTM Net Income | -$894.00M | -7.8% | -47.5% | -65.7% | -473.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$537.60M | N/A | -29.4% |
| 3Y | -$471.59M | N/A | -47.5% |
| 5Y | -$124.54M | N/A | -458.3% |
| All | $29.40M | -2465.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$695.36M | at low | |
| 3Y | -$695.36M | at low | |
| 5Y | -$695.36M | at low | |
| All | -$695.36M | at low |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of CYTK?
- As of today, CYTK TTM EBITDA is -$695.36M
- What is CYTK TTM EBITDA most recent change?
- CYTK TTM EBITDA was down -10.54% on June 30, 2026
- What is 1-year change in CYTK TTM EBITDA?
- CYTK TTM EBITDA is down -29.35% year-over-year
- How far is CYTK TTM EBITDA from its all-time high?
- CYTK TTM EBITDA is currently -2465.10% below its historical high of $29.40M set on September 30, 2009
- How does CYTK TTM EBITDA rank versus sector peers?
- CYTK TTM EBITDA is higher than 0.76% of companies in Healthcare sector
- When is CYTK next earnings release?
- The next earnings release for CYTK is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk
